Cargando…
Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma
Uveal melanoma (UM) is the most common primary intraocular tumour in adults, with a mean survival of six months following metastasis. The survival rates have not improved in over 30 years. This study has shown that sister chromatid exchange (SCE) is low in UM which is likely due to a reduced express...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769470/ https://www.ncbi.nlm.nih.gov/pubmed/31480356 http://dx.doi.org/10.3390/cancers11091278 |
_version_ | 1783455244674400256 |
---|---|
author | Doherty, Rachel E. Bryant, Helen E. Valluru, Manoj K. Rennie, Ian G. Sisley, Karen |
author_facet | Doherty, Rachel E. Bryant, Helen E. Valluru, Manoj K. Rennie, Ian G. Sisley, Karen |
author_sort | Doherty, Rachel E. |
collection | PubMed |
description | Uveal melanoma (UM) is the most common primary intraocular tumour in adults, with a mean survival of six months following metastasis. The survival rates have not improved in over 30 years. This study has shown that sister chromatid exchange (SCE) is low in UM which is likely due to a reduced expression of FANCD2. As FANCD2 can function to suppress non-homologous end joining (NHEJ), this study therefore investigated NHEJ in UM. The activation of the catalytic subunit of the NHEJ pathway protein DNA-dependent protein kinase (DNA-PK) was measured by analysing the foci formation and the ligation efficiency by NHEJ determined using a plasmid-based end-joining assay. Using small-interfering RNA (siRNA) knock-down, and chemical inhibitors of DNA-PK, the survival of primary UM cultures and two cell lines were determined. To assess the homologous recombination capacity in response to the inhibition of DNA-PK, a SCE analysis was performed. In addition, to support the findings, the messenger RNA (mRNA) expression of genes associated with NHEJ was analysed using the Cancer Genome Atlas (TCGA)-UM RNAseq data (n = 79). The NHEJ activity and DNA-PKcs activation was upregulated in UM and the inhibition of DNA-PK selectively induced apoptosis and sensitized to ionising radiation and inter-strand cross-linking agents. The inhibition of the NHEJ protein DNA-PK is lethal to UM, indicating a potentially effective therapeutic option, either alone or as a sensitizer for other treatments. |
format | Online Article Text |
id | pubmed-6769470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67694702019-10-30 Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma Doherty, Rachel E. Bryant, Helen E. Valluru, Manoj K. Rennie, Ian G. Sisley, Karen Cancers (Basel) Article Uveal melanoma (UM) is the most common primary intraocular tumour in adults, with a mean survival of six months following metastasis. The survival rates have not improved in over 30 years. This study has shown that sister chromatid exchange (SCE) is low in UM which is likely due to a reduced expression of FANCD2. As FANCD2 can function to suppress non-homologous end joining (NHEJ), this study therefore investigated NHEJ in UM. The activation of the catalytic subunit of the NHEJ pathway protein DNA-dependent protein kinase (DNA-PK) was measured by analysing the foci formation and the ligation efficiency by NHEJ determined using a plasmid-based end-joining assay. Using small-interfering RNA (siRNA) knock-down, and chemical inhibitors of DNA-PK, the survival of primary UM cultures and two cell lines were determined. To assess the homologous recombination capacity in response to the inhibition of DNA-PK, a SCE analysis was performed. In addition, to support the findings, the messenger RNA (mRNA) expression of genes associated with NHEJ was analysed using the Cancer Genome Atlas (TCGA)-UM RNAseq data (n = 79). The NHEJ activity and DNA-PKcs activation was upregulated in UM and the inhibition of DNA-PK selectively induced apoptosis and sensitized to ionising radiation and inter-strand cross-linking agents. The inhibition of the NHEJ protein DNA-PK is lethal to UM, indicating a potentially effective therapeutic option, either alone or as a sensitizer for other treatments. MDPI 2019-08-30 /pmc/articles/PMC6769470/ /pubmed/31480356 http://dx.doi.org/10.3390/cancers11091278 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Doherty, Rachel E. Bryant, Helen E. Valluru, Manoj K. Rennie, Ian G. Sisley, Karen Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma |
title | Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma |
title_full | Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma |
title_fullStr | Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma |
title_full_unstemmed | Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma |
title_short | Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma |
title_sort | increased non-homologous end joining makes dna-pk a promising target for therapeutic intervention in uveal melanoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769470/ https://www.ncbi.nlm.nih.gov/pubmed/31480356 http://dx.doi.org/10.3390/cancers11091278 |
work_keys_str_mv | AT dohertyrachele increasednonhomologousendjoiningmakesdnapkapromisingtargetfortherapeuticinterventioninuvealmelanoma AT bryanthelene increasednonhomologousendjoiningmakesdnapkapromisingtargetfortherapeuticinterventioninuvealmelanoma AT vallurumanojk increasednonhomologousendjoiningmakesdnapkapromisingtargetfortherapeuticinterventioninuvealmelanoma AT rennieiang increasednonhomologousendjoiningmakesdnapkapromisingtargetfortherapeuticinterventioninuvealmelanoma AT sisleykaren increasednonhomologousendjoiningmakesdnapkapromisingtargetfortherapeuticinterventioninuvealmelanoma |